Synchrony Financial insider plans sale of 4,000 shares

Synchrony Financial (SYF) has a beneficial owner filing a notice to potentially sell 4,000 shares of common stock through Raymond James & Associates Inc. on the NYSE.

Rhea-AI Filing Summary

Synchrony Financial (SYF) has a beneficial owner filing a notice to potentially sell 4,000 shares of common stock through Raymond James & Associates Inc. on the NYSE. The filing lists these shares as previously acquired as compensation on several dates between June 2021 and December 2024.

The notice also references an aggregate market value of $25,240,000,000.00 and 325,370,840 common shares outstanding as of August 3, 2026, as context for the issuer’s size.

Key Figures

Planned shares to be sold: 4,000 shares Aggregate market value: $25,240,000,000.00 Shares outstanding: 325,370,840 shares +4 more

7 metrics

Planned shares to be sold 4,000 shares Common stock sale notice through Raymond James & Associates Inc.

Aggregate market value $25,240,000,000.00 Aggregate market value referenced for Synchrony Financial

Shares outstanding 325,370,840 shares Common shares outstanding as of August 3, 2026

Compensation grant 1 1,565 shares Acquired as compensation on 06/30/2021

Compensation grant 2 1,319 shares Acquired as compensation on 09/30/2021

Compensation grant 3 991 shares Acquired as compensation on 12/31/2021

Compensation grant 4 125 shares Acquired as compensation on 12/31/2024

Key Terms

Form 144, acquired as comp, aggregate market value, shares outstanding

4 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

acquired as comp financial

"Common | 06/30/2021 | Acquired as comp | Issuer"

aggregate market value financial

"4000 | 25240000000.00 | 325370840 | 08/03/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

shares outstanding financial

"25240000000.00 | 325370840 | 08/03/2026"

Shares outstanding are the total number of a company’s stock units held by all shareholders, including institutional investors and company insiders — think of them as the total number of slices of the company’s ownership pie. Investors use this number to calculate how much of the company each share represents, and it directly affects per-share measures like earnings per share, ownership percentage and valuation; when the slice count changes, an investor’s claim and the company’s per-share metrics change too.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Synchrony Financial (SYF) report in this Form 144 notice?

The notice states that a holder plans to potentially sell 4,000 shares of SYF common stock through Raymond James & Associates Inc. on the NYSE, with the shares having been acquired as compensation over prior years.

How many Synchrony Financial (SYF) shares are covered by the proposed sale?

The proposed sale covers 4,000 shares of SYF common stock. These shares are tied to multiple prior grants described as acquired as compensation on several dates between 2021 and 2024.

How were the SYF shares in this Form 144 acquired by the seller?

The filing describes the securities as acquired as compensation. It lists multiple compensation-related acquisitions of SYF common stock on dates including 06/30/2021, 09/30/2021, 12/31/2021, and 12/31/2024 with specified share amounts.

What context about Synchrony Financial (SYF) is provided regarding its size?

The notice references an aggregate market value of $25,240,000,000.00 and 325,370,840 SYF common shares outstanding as of August 3, 2026, providing context on the issuer’s overall equity size.

Which broker is listed for the planned Synchrony Financial (SYF) share sale?

The filing lists Raymond James & Associates Inc., located at 880 Carillon Parkway, St. Petersburg, FL 33716, in connection with the proposed sale of 4,000 SYF common shares on the NYSE.

What historical SYF compensation grants are detailed in this Form 144?

The document lists several compensation-based acquisitions of SYF common stock: 1,565 shares on 06/30/2021, 1,319 shares on 09/30/2021, 991 shares on 12/31/2021, and 125 shares on 12/31/2024, all described as acquired as comp.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 01:41 PM Accepted by SEC EDGAR 08/03/2026 - 01:41 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001206587
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Synchrony Financial
SEC File Number	001-36560
Address of Issuer	777 LONG RIDGE ROAD STAMFORD CONNECTICUT 06902-1250
Phone	203 585-2400
Name of Person for Whose Account the Securities are To Be Sold	COVIELLO ARTHUR W JR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James and Associates Inc. 880 Carillon Parkaway St. Petersburg FL 33716	4000	25240000000.00	325370840	08/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2021	Acquired as comp	Issuer			1565	06/30/2021	NA
Common	09/30/2021	Acquired as comp	issuer			1319	09/30/2021	NA
Common	12/31/2021	Acquired as comp	Issuer			991	12/31/2021	NA
Common	12/31/2024	Acquired as comp	issuer			125	12/31/2024	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Arthur W Coviello Jr.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)